Centogene NV
NASDAQ:CNTG
Centogene NV
Total Current Liabilities
Centogene NV
Total Current Liabilities Peer Comparison
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Centogene NV
NASDAQ:CNTG
|
Total Current Liabilities
€43.4m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
BioNTech SE
NASDAQ:BNTX
|
Total Current Liabilities
€2.1B
|
CAGR 3-Years
51%
|
CAGR 5-Years
75%
|
CAGR 10-Years
N/A
|
|
MorphoSys AG
XETRA:MOR
|
Total Current Liabilities
€487.8m
|
CAGR 3-Years
34%
|
CAGR 5-Years
59%
|
CAGR 10-Years
31%
|
|
CureVac NV
NASDAQ:CVAC
|
Total Current Liabilities
€186.4m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
Immatics NV
NASDAQ:IMTX
|
Total Current Liabilities
€156.6m
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Biotest AG
XETRA:BIO
|
Total Current Liabilities
€391.2m
|
CAGR 3-Years
48%
|
CAGR 5-Years
29%
|
CAGR 10-Years
12%
|
See Also
What is Centogene NV's Total Current Liabilities?
Total Current Liabilities
43.4m
EUR
Based on the financial report for Dec 31, 2023, Centogene NV's Total Current Liabilities amounts to 43.4m EUR.
What is Centogene NV's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
12%
Over the last year, the Total Current Liabilities growth was 76%. The average annual Total Current Liabilities growth rates for Centogene NV have been -9% over the past three years , 12% over the past five years .